SUMMARY Chromosome heteromorphisms, restriction fragment length polymorphisms, or both were used to study the parental origin of 33 cases of simple trisomy 13 4, 9, 13, 14, 15, 16, 21, and 22.4 Cytogenetic heteromorphisms have provided useful information on the relative importance of different meiotic errors to the genesis of trisomy, but there are several important limitations to the technique. For example, the X chromosome and the majority of the autosomes are not heteromorphic and therefore cannot be studied with this method, and there is relatively little variation in the heteromorphic regions of several other chromosomes (for example, 3, 4, 9, and 16). Furthermore, analysis of the variants involves subjective evaluation of size and staining intensity and, even when the scoring is done blindly and by independent observers, it is possible that a small proportion of parental origin assignments will be wrong.
Almost all information on the parental origin of autosomal trisomy has come from analysis of chromosome heteromorphisms, cytologically detectable variants which occur regularly on 10 of the 22 autosomes. This technique has been most extensively used to investigate the origin of trisomy 21 in liveborns and data are now available on over 1000 families.' 2 Additionally, there are limited data on liveborn subjects with trisomy 133 and on spontaneously aborted conceptuses with trisomies 3, 4, 9, 13, 14, 15, 16, 21, and 22.4 Cytogenetic heteromorphisms have provided useful information on the relative importance of different meiotic errors to the genesis of trisomy, but there are several important limitations to the technique. For example, the X chromosome and the majority of the autosomes are not heteromorphic and therefore cannot be studied with this method, and there is relatively little variation in the heteromorphic regions of several other chromosomes (for example, 3, 4, 9, and 16). Furthermore, analysis of the variants involves subjective evaluation of size and staining intensity and, even when the scoring is done blindly and by independent observers, it is possible that a small proportion of parental origin assignments will be wrong.
Some of these difficulties can now be overcome by applying restriction fragment length polymorphism Received for publication 3 April 1987. Accepted for publication 21 April 1987. (RFLP) analysis to the study of the origin of trisomy. The advantages of this approach are that (1) the detection of allelic variation using RFLPs is objective; (2) the DNA fragments show gene dosage, a prerequisite for determination of the parental origin of trisomies using a two allele system, and (3) the availability of multiple polymorphisms on each chromosome makes it likely that the parental origin of virtually every trisomy can be unambiguously determined. Preliminary results from studies that have used RFLPs clearly show the efficiency of this method. 5 Additionally, by combining analysis of chromosome heteromorphisms with analysis of RFLPs, it is now possible to address questions which were previously intractable. One of the most interesting of these is the possibility that aberrant levels of recombination may be important in non-disjunction. In species with chiasmate meiosis, maintenance of pairing in meiosis I is presumably dependent on the presence of at least one chiasma per bivalent.! Thus, reduction or elimination of crossing over may lead to univalent formation and ultimately to nondisjunction and there is some evidence from studies of experimental animals7 8 to suggest that this may be an important source of trisomy. Furthermore, if multiple exchanges impede the orderly separation of bivalents at anaphase I, abnormally high levels of recombination might also be associated with non-Both of these suggestions can now be directly tested in humans by using centromere mapping techniques to compare the frequency of crossing over in normal meioses and meioses resulting in trisomy. The mapping method using trisomy is essentially the same as that previously described for ovarian teratomas,9 that is, chromosome heteromorphisms or pericentromeric RFLPs Subsequently the paternal chromosome 13 was lost, presumably at an early division of the zygote, as mosaicism was present in both blood and skin. Thus the 'normal' cell line was, in fact, disomic for a maternal chromosome 13 and had no paternal contribution.
The two remaining cases were both double aneuploids, with K2707 being trisomic for chromosome 21 and K3362 being monosomic for the X as well as being trisomic for 13. In the former case, we were unable to determine the parental origin of the additional chromosome 21, but could not exclude an error at maternal meiosis I (the source of the extra chromosome 13). In the latter case, analysis of X linked RFLPs indicated that the single X was maternal in origin and, by combining the cytogenetic with the molecular results (table 3), the origin of the additional chromosome 13 was determined to be non-disjunction at paternal meiosis I. Thus, in this instance, both fetal chromosome abnormalities involved the paternal complement. based on a limited number of cases, but it is substantiated by cytogenetic studies of trisomy 21, which have consistently found the highest maternal ages to be associated with non-disjunction at maternal meiosis 11.2 Thus, it seems likely that maternal age adversely affects chromosome segregation at both meiotic divisions. As recombination occurs only at the first meiotic division, it is doubtful that a deleterious effect of increasing age on recombination is the mechanism responsible for the dramatic increase in non-disjunction with advancing age. Instead, it seems more likely that ageing affects organelles such as the centromere or the spindle, which are common to both meiotic divisions.
PARENTAL ORIGIN OF TRANSLOCATION TRISOMY 13 Table 3 summarises results on the seven trisomies and one translocation trisomy which were studied using both RFLPs and chromosome heteromorphisms. We were able to determine the parent and meiotic stage of origin of the additional chromosome in all seven trisomies, and therefore in each case were able to study crossing over between the centromere and the loci tested.
Crossing over between the two non-disjoined chromosomes clearly occurred in at least two of three trisomies of maternal meiosis I origin (fig 2) . In K3177, heterozygosity in the mother was reduced to homozygosity in the fetus at D13S1, D13S7, and D13S5. Similarly, in K3325 heterozygosity was reduced at D13SJ and D1355, with D13S7 being uninformative. Thus, in both trisomies the most economical explanation of the results is a single exchange between the centromere and the most proximal locus (D1351) with no evidence for further recombination. In the other trisomy of maternal meiosis I origin (K3283) maternal heterozygosity was maintained for all three informative loci (D13S1, D13S4, and D13S3) and therefore we were unable to document an exchange between the two non-disjoined chromosomes.
We were also able to document crossing over in two of the remaining four trisomies. In K3992, one of the two cases of maternal meiosis II origin, heterozygosity was reduced to homozygosity at D13SJ, consistent with no crossing over between the centromere and this locus. However, the fetus was heterozygous for the HindIII polymorphism at D13S5, indicating that a cross over had occurred between D13SJ and D13S5. In K2766, we identified a cross over between the centromere and D13S5, the only locus for which the parental RFLPs were potentially informative. We were unable to identify recombinants in the other two cases, but in one (X16) only one locus was potentially informative and in the other (K3362) there were no informative loci.
In the translocation trisomy 13 (Xl1), analysis of both cytogenetic and molecular markers indicated a paternal origin for the abnormality. Additionally, The present study also shows the utility of combining molecular and cytogenetic techniques to study non-disjunction. We were able to determine the parent and meiotic stage of origin in all seven trisomies studied, while with cytogenetic techniques alone this was possible in only two-thirds of the cases and with RFLPs the parent of origin was determined in only half of the cases. Furthermore, the combined use of the two techniques provides the basis for centromere mapping and, while we have only limited data from a small number of trisomy 13 cases, our results are nevertheless of interest with regard to linkage studies of chromosome 13.
Leppert et al17 have recently presented a genetic map of chromosome 13, using the same DNA markers as in the present study. In that analysis, the male map distance from the two most proximal loci (D13S6) and (D13S1) to the most distal locus (D13S5) was approximately 70 cM, and from a consideration of the approximate physical assignments of these loci, it might be concluded that they span most of the long arm. However, in our preliminary observations, we have already detected recombination between the centromere and D13SJ in two of four informative cases. Thus, on the basis of these limited data it is unlikely that the centromere and D13SJ are tightly linked.
Additionally, our results are of considerable interest in view of the purported association between reduced recombination in maternal meiosis I and trisomy 21.10 Specifically, we have evidence for recombination in two of the three cases in which the extra chromosome originated in maternal meiosis I, as well as in the single paternal meiosis I case where information on recombination was obtained. These are preliminary observations but, nevertheless, they clearly show that failure to pair is not the only mechanism responsible for nondisjunction in man. However, it is still possible that a proportion of the cases are the result of asynapsis (for example, in K3283 recombinants were not observed in three opportunities), or that a proportion are related to decreased or increased levels of recombination. A much more extensive series of cases, including trisomies with different parental and meiotic origins and involving parents in different age categories, must be examined before the possible role of recombination in the genesis of human trisomy is fully understood.
